Stockscreener 앱 받기
4.35
4.19%
-0.19
전일 마감가:
$4.54
열려 있는:
$4.61
하루 거래량:
48,656
Relative Volume:
0.18
시가총액:
$641.07M
수익:
-
순이익/손실:
$-54.17M
주가수익비율:
-11.76
EPS:
-0.3699
순현금흐름:
$-39.34M
1주 성능:
+1,551%
1개월 성능:
+1,036%
6개월 성능:
+1,103%
1년 성능:
+131.38%
1일 변동 폭
$4.165
$4.61
1주일 범위
$4.165
$5.36
52주 변동 폭
$0.2561
$5.36
Immutep Limited Adr Stock (IMMP) Company Profile
Compare IMMP vs VRTX, MRNA, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
4.35 | 38.83M | 0 | -54.17M | -39.34M | -0.3699 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-13 | 다운그레이드 | Citizens | Mkt Outperform → Mkt Perform |
| 2026-03-13 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2026-03-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2026-02-17 | 개시 | Citizens | Mkt Outperform |
| 2024-05-17 | 개시 | CapitalOne | Overweight |
| 2023-08-03 | 개시 | Robert W. Baird | Outperform |
| 2021-08-03 | 개시 | Ladenburg Thalmann | Buy |
| 2021-07-16 | 재개 | Maxim Group | Buy |
| 2018-09-28 | 개시 | B. Riley FBR | Buy |
| 2018-02-15 | 재확인 | Maxim Group | Buy |
모두보기
Immutep Limited Adr 주식(IMMP)의 최신 뉴스
Net income of Immutep Ltd Sponsored ADR – HAM:YP1 - TradingView
Immutep Limited (IMMP) Stock Price, News, Quote & History - Yahoo! Finance Canada
Equity in earnings of Immutep Ltd Sponsored ADR – FWB:YP1 - TradingView
Immutep Ltd Sponsored ADR Earnings and Revenue – FWB:YP1 - TradingView
Immutep Ltd Sponsored ADR Earnings and Revenue – SWB:YP1 - TradingView
Head and Neck Squamous Cell Carcinoma (HNSCC)Market Insights, Epidemiology, and Market Forecast - GlobeNewswire Inc.
Immutep Ltd Sponsored ADR Cash Flow – MUN:YP1 - TradingView
IMMP: Static price chart | Immutep Limited | US45257L1089 - marketscreener.com
Immutep (NASDAQ: IMMP) Announces ADS Ratio Adjustment Effective September 28 to Meet Nasdaq Price Criteria - kalkinemedia.com
Immutep (IMMP) plans 1-for-20 ADS reverse split to address Nasdaq bid-price deficiency - Stock Titan
Immutep Ltd ADR (NASDAQ: IMMP) Share Price, IMMP Stock News, IMMP Share Price & Updates - kalkine.ca
Immutep (NASDAQ: IMMP) halts Phase III lung cancer trial and returns cash to Dr Reddy’s - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming DeadlinesIMMP - Eastern Progress
Immutep Ltd Sponsored ADR Revenue Breakdown – FWB:YP1A - TradingView
Immutep Ltd Sponsored ADR Revenue Breakdown – MUN:YP1A - TradingView
What Triggered Immutep's Securities Class Action Lawsuit - Kavout | AI
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight - GlobeNewswire Inc.
Citizens maintains Immutep stock rating on cash analysis - Investing.com
Immutep (ASX:IMM) Shares Surge Nearly 14% as Healthcare Momentum Grabs the ASX Spotlight - Kalkine
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - PR Newswire
YP1A Forecast — Price Target — Prediction for 2027 - TradingView
Class action lawsuit filed against Immutep afte... - Pluang
Immutep Limited Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsIMMP - Finansavisen
A2H8YL Forecast — Price Target — Prediction for 2027 - TradingView
IMMP Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
IMMP Investor AlertImmutep Limited Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit - Morningstar
IMM:ASX AnnouncementChange in substantial holding09 Jun 2026 - Market Index
IMMP UPCOMING DEADLINE: Levi & Korsinsky Alerts Immutep Limited Stockholders of Securities Class Action - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
רוזן, יועץ למשקיעים מוביל, מעודד את משקיעי Immutep Ltd. לקבל ייעוץ משפטי לפני מועד אחרון חשוב בתביעה ייצוגית לניירות ערך - GlobeNewswire Inc.
IMMP Investors Have Opportunity to Lead Immutep Ltd. Securities Fraud Lawsuit - Morningstar
IMMP DEADLINE: Levi & Korsinsky Reminds Immutep Limited Investors of Upcoming Securities Class Action Deadline - Finansavisen
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
IMMP Shareholder Alert: Immutep Limited Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Finansavisen
IMMP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - TMX Newsfile
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel ... - Caledonian Record
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
IMMP - Finviz
SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026IMMP - Barchart
Immutep Limited Adr (IMMP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
0.82%
자본화:
|
볼륨(24시간):